Combination Therapy with Bactrim and Keflex for Wound Infection
Using both Bactrim (trimethoprim-sulfamethoxazole) and Keflex (cephalexin) together for 14 days is not recommended and provides no additional benefit over monotherapy for wound infections. Choose one antibiotic based on the specific characteristics of your wound infection.
Why Combination Therapy Is Not Indicated
The evidence clearly demonstrates that adding TMP-SMX to cephalexin does not improve cure rates:
For wound infections specifically: A randomized trial showed clindamycin and TMP-SMX alone produced equivalent cure rates (92.1% vs 91.9%) in uncomplicated wound infections, with no role for combination therapy 1
For cellulitis: Two high-quality randomized trials found that cephalexin plus TMP-SMX was not superior to cephalexin alone. The per-protocol cure rates were actually slightly lower with combination therapy (83.5% vs 85.5%) 2, and another trial showed no benefit (85% vs 82% cure rates) 3
How to Choose the Right Single Agent
For Purulent Wound Infections (with pus/drainage):
- Use TMP-SMX alone or clindamycin
- IDSA guidelines specifically recommend TMP-SMX, clindamycin, or doxycycline when MRSA is suspected 4
- MRSA is found in 40-62% of purulent wound cultures 1, 5
For Non-purulent Wound Infections (no pus):
- Use cephalexin alone (500 mg four times daily)
- Covers methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci
- IDSA guidelines support cephalexin for non-purulent infections 4
Duration: 7 Days, Not 14 Days
The standard duration is 7 days, not 14 days 4, 2, 1. IDSA guidelines recommend 7-day regimens for skin and soft tissue infections 4. The clinical trials demonstrating efficacy all used 7-day courses 2, 3, 1.
Critical Safety Concerns with Combination Therapy
Using both drugs simultaneously increases risks without benefit:
- Drug interactions: Bactrim inhibits CYP2C8, CYP2C9, and OCT2 transporters, potentially affecting other medications 6
- Electrolyte abnormalities: TMP-SMX can cause hyperkalemia and hyponatremia 6
- Increased adverse events: Higher pill burden without improved outcomes
- Antibiotic resistance: Unnecessary broad-spectrum coverage promotes resistance 6, 7
Practical Algorithm
Assess for purulence: Is there pus, drainage, or abscess?
- Yes → TMP-SMX DS (800/160 mg) twice daily for 7 days
- No → Cephalexin 500 mg four times daily for 7 days
Consider MRSA risk factors: Previous MRSA infection, high local prevalence, injection drug use
- Present → TMP-SMX preferred
- Absent → Cephalexin appropriate
Ensure adequate drainage: Incision and drainage is essential for purulent infections; antibiotics are adjunctive 4
Common Pitfalls to Avoid
- Don't prescribe combination therapy reflexively thinking "more is better"—the evidence shows no benefit 2, 3
- Don't extend to 14 days routinely—7 days is standard and evidence-based 4
- Don't use TMP-SMX for non-purulent cellulitis alone—it lacks adequate streptococcal coverage 8
- Monitor for recurrence: TMP-SMX had higher recurrence rates (7.1%) compared to clindamycin (2.0%) in one trial 1
Bottom line: Select ONE antibiotic based on wound characteristics, use for 7 days, and ensure proper wound care including drainage if indicated.